Corvus Pharmaceuticals, Inc. SEC filings CRVS

Corvus Pharmaceuticals, Inc. has 583 filings in SEC EDGAR's recent list, going back to Dec 8, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Corvus Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Jul 22, 2026 Jul 21, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
8-K Current report
Regulation FD disclosure, Other events
May 14, 2026 May 14, 2026
S-8 Employee stock plan registration May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Apr 23, 2026 Apr 22, 2026
8-K Current report
Material agreement
Mar 13, 2026 Mar 13, 2026
424B5 Prospectus supplement Mar 13, 2026 —
S-3ASR Automatic shelf registration Mar 13, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Other events
Jan 23, 2026 Jan 21, 2026
424B5 Prospectus supplement Jan 23, 2026 —
S-3MEF Filing Jan 21, 2026 —
424B5 Prospectus supplement Jan 20, 2026 —
8-K Current report
Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 20, 2026 Jan 20, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Officer or director change
Oct 2, 2025 Oct 2, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2025 Jun 4, 2025
S-8 Employee stock plan registration May 8, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 12, 2025
8-K Current report
Officer or director change
Apr 9, 2025 Apr 8, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 25, 2025 Mar 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 18, 2024 Dec 18, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement
Oct 23, 2024 Oct 22, 2024
EFFECT Filing Aug 15, 2024 —
CORRESP Letter to the SEC Aug 13, 2024 —
UPLOAD Letter from the SEC Aug 13, 2024 —
S-3 Shelf registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 13, 2024
S-8 Employee stock plan registration May 7, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Material agreement
May 6, 2024 May 1, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
424B5 Prospectus supplement May 3, 2024 —
8-K Current report
Other events
May 1, 2024 May 1, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 13, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
8-K Current report
Officer or director change, Other events
Jan 23, 2024 Jan 23, 2024
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Other events
Sep 7, 2023 Sep 6, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 21, 2023 Jun 15, 2023
EFFECT Filing May 8, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
CORRESP Letter to the SEC May 4, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 15, 2023
8-K Current report
Other events
Apr 24, 2023 Apr 21, 2023
8-K Current report
Officer or director change
Apr 3, 2023 Mar 29, 2023
UPLOAD Letter from the SEC Mar 31, 2023 —
8-K Current report
Agreement ended
Mar 29, 2023 Mar 28, 2023
S-3 Shelf registration Mar 29, 2023 —
S-8 Employee stock plan registration Mar 28, 2023 —
10-K Annual report Mar 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
8-K/A Amended current report
Shareholder vote results
Nov 3, 2022 Jun 15, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Listing notice
Oct 28, 2022 Oct 25, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 15, 2022
S-8 Employee stock plan registration May 5, 2022 —
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 15, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
8-K Current report
Material agreement
Nov 2, 2021 Nov 1, 2021
424B5 Prospectus supplement Nov 2, 2021 —
10-Q Quarterly report Nov 1, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 1, 2021 Nov 1, 2021
10-Q Quarterly report Aug 2, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 2, 2021 Aug 2, 2021
8-K Current report
Results of operations, Other events
Jul 15, 2021 Jul 15, 2021
8-K Current report
Shareholder vote results
Jun 16, 2021 Jun 15, 2021
S-8 Employee stock plan registration Apr 29, 2021 —
10-Q Quarterly report Apr 29, 2021 Mar 31, 2021
8-K Current report
Results of operations
Apr 29, 2021 Apr 29, 2021
DEFA14A Additional proxy material Apr 20, 2021 —
DEF 14A Proxy statement Apr 20, 2021 Jun 15, 2021
SEC STAFF LETTER Filing Mar 29, 2021 —
10-K Annual report Mar 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 25, 2021 Mar 25, 2021
8-K Current report
Officer or director change
Mar 22, 2021 Mar 18, 2021
SEC STAFF LETTER Filing Mar 1, 2021 —
8-K Current report
Other events
Feb 17, 2021 Feb 12, 2021
424B5 Prospectus supplement Feb 12, 2021 —
424B5 Prospectus supplement Feb 11, 2021 —
8-K Current report
Results of operations
Feb 11, 2021 Feb 11, 2021
8-K Current report
Other events
Feb 4, 2021 Feb 4, 2021
8-K Current report
Officer or director change
Dec 17, 2020 Dec 16, 2020
8-K Current report
Other events
Dec 7, 2020 Dec 6, 2020
8-K Current report
Other events
Nov 9, 2020 Nov 9, 2020
10-Q Quarterly report Oct 29, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 29, 2020 Oct 29, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Oct 5, 2020 Oct 5, 2020
8-K Current report
Other events
Sep 17, 2020 Sep 17, 2020
8-K Current report
Officer or director change
Sep 11, 2020 Sep 10, 2020
8-K Current report
Other events
Sep 10, 2020 Sep 10, 2020
10-Q Quarterly report Jul 30, 2020 Jun 30, 2020
8-K Current report
Results of operations
Jul 30, 2020 Jul 30, 2020
8-K Current report
Other events
Jul 7, 2020 Jul 7, 2020
8-K Current report
Shareholder vote results
Jun 10, 2020 Jun 9, 2020
8-K Current report
Other events
May 29, 2020 May 29, 2020
S-8 Employee stock plan registration Apr 30, 2020 —
10-Q Quarterly report Apr 30, 2020 Mar 31, 2020
8-K Current report
Results of operations
Apr 30, 2020 Apr 30, 2020
DEFA14A Additional proxy material Apr 15, 2020 —
DEF 14A Proxy statement Apr 15, 2020 Jun 9, 2020
8-K Current report
Officer or director change
Mar 20, 2020 Mar 19, 2020
424B5 Prospectus supplement Mar 20, 2020 —
EFFECT Filing Mar 19, 2020 —
CORRESP Letter to the SEC Mar 17, 2020 —
UPLOAD Letter from the SEC Mar 12, 2020 —
S-3 Shelf registration Mar 9, 2020 —
10-K Annual report Mar 9, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 5, 2020 Mar 5, 2020
8-K Current report
Regulation FD disclosure
Feb 13, 2020 Feb 13, 2020
8-K Current report
Regulation FD disclosure
Feb 3, 2020 Feb 1, 2020
8-K Current report
Officer or director change
Dec 16, 2019 Dec 12, 2019
8-K Current report
Regulation FD disclosure
Dec 9, 2019 Dec 7, 2019
8-K Current report
Material agreement, Unregistered share sale
Nov 12, 2019 Nov 8, 2019
8-K Current report
Regulation FD disclosure, Other events
Nov 8, 2019 Nov 8, 2019
10-Q Quarterly report Oct 29, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 29, 2019 Oct 29, 2019
10-Q Quarterly report Aug 1, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 1, 2019 Aug 1, 2019
8-K Current report
Shareholder vote results
Jun 24, 2019 Jun 20, 2019
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2019 Jun 2, 2019
S-8 Employee stock plan registration May 9, 2019 —
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEFA14A Additional proxy material Apr 24, 2019 —
DEF 14A Proxy statement Apr 24, 2019 Jun 20, 2019
10-K Annual report Mar 7, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 7, 2019 Mar 7, 2019
8-K Current report
Regulation FD disclosure
Feb 6, 2019 Feb 6, 2019
8-K Current report
Officer or director change
Jan 28, 2019 Jan 28, 2019
8-K Current report
Regulation FD disclosure
Jan 10, 2019 Jan 10, 2019
8-K Current report
Regulation FD disclosure
Jan 8, 2019 Jan 8, 2019
8-K Current report
Officer or director change
Dec 14, 2018 Dec 12, 2018
8-K Current report
Regulation FD disclosure
Nov 13, 2018 Nov 10, 2018
10-Q Quarterly report Nov 1, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 1, 2018 Nov 1, 2018
8-K Current report
Regulation FD disclosure
Oct 22, 2018 Oct 22, 2018
8-K Current report
Regulation FD disclosure
Oct 3, 2018 Oct 3, 2018
UPLOAD Letter from the SEC Aug 24, 2018 —
CORRESP Letter to the SEC Aug 17, 2018 —
10-K/A Amended annual report Aug 17, 2018 Dec 31, 2017
10-Q Quarterly report Aug 2, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 2, 2018 Aug 2, 2018
UPLOAD Letter from the SEC Aug 1, 2018 —
8-K Current report
Regulation FD disclosure
Jun 28, 2018 Jun 28, 2018
8-K Current report
Shareholder vote results
Jun 22, 2018 Jun 21, 2018
10-Q Quarterly report May 3, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 3, 2018 May 3, 2018
DEFA14A Additional proxy material Apr 27, 2018 —
DEF 14A Proxy statement Apr 27, 2018 Jun 21, 2018
8-K Current report
Other events
Apr 26, 2018 Apr 26, 2018
8-K Current report
Other events
Mar 21, 2018 Mar 8, 2018
S-8 Employee stock plan registration Mar 13, 2018 —
424B5 Prospectus supplement Mar 9, 2018 —
424B5 Prospectus supplement Mar 7, 2018 —
10-K Annual report Mar 1, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 1, 2018 Mar 1, 2018
8-K Current report
Other events
Feb 1, 2018 Feb 1, 2018
8-K Current report
Officer or director change
Dec 15, 2017 Dec 13, 2017
8-K Current report
Other events
Nov 13, 2017 Nov 11, 2017
10-Q Quarterly report Nov 2, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 2, 2017 Nov 2, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CRVS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1626971

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.